|
|
Article: Stadtlanders Pharmacy and DuPont Merck Announce Joint Development Agreement; Advanced Program to Enhance Quality of Care for Parkinson's Patients
- Article from:
- PR Newswire
- Article date:
- September 29, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PITTSBURGH, and WILMINGTON, Del., Sept. 29 /PRNewswire/ -- Stadtlanders Pharmacy, a nationwide provider of disease-specific pharmacy services, and The DuPont Merck Pharmaceutical Company, a leader in Parkinson's disease therapies, jointly announce a long-term agreement intended to enhance the quality of care for Parkinson's patients.
Currently in the design stage, the program supports a patient-oriented "best care" approach designed to enhance care through patient education and additional support services to the physician community treating Parkinson's patients.
Components of the program include:
-- Specialized clinical and educational ...